ETNB
Price
$5.79
Change
-$1.06 (-15.45%)
Updated
Apr 4, 02:35 PM (EDT)
Capitalization
1B
33 days until earnings call
OBIO
Price
$2.72
Change
-$0.39 (-12.54%)
Updated
Apr 4, 02:39 PM (EDT)
Capitalization
116.09M
Ad is loading...

ETNB vs OBIO

Header iconETNB vs OBIO Comparison
Open Charts ETNB vs OBIOBanner chart's image
89bio
Price$5.79
Change-$1.06 (-15.45%)
Volume$801
Capitalization1B
Orchestra BioMed Holdings
Price$2.72
Change-$0.39 (-12.54%)
Volume$2.35K
Capitalization116.09M
ETNB vs OBIO Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. OBIO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and OBIO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ETNB: $6.86 vs. OBIO: $3.11)
Brand notoriety: ETNB and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 76% vs. OBIO: 116%
Market capitalization -- ETNB: $1B vs. OBIO: $116.09M
ETNB [@Biotechnology] is valued at $1B. OBIO’s [@Biotechnology] market capitalization is $116.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 4 TA indicator(s) are bullish while OBIO’s TA Score has 4 bullish TA indicator(s).

  • ETNB’s TA Score: 4 bullish, 6 bearish.
  • OBIO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than ETNB.

Price Growth

ETNB (@Biotechnology) experienced а -23.44% price change this week, while OBIO (@Biotechnology) price change was -32.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

ETNB is expected to report earnings on May 07, 2025.

OBIO is expected to report earnings on Jan 25, 2023.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1B) has a higher market cap than OBIO($116M). ETNB YTD gains are higher at: -12.276 vs. OBIO (-22.250). OBIO has higher annual earnings (EBITDA): -59.81M vs. ETNB (-361.06M). ETNB has more cash in the bank: 440M vs. OBIO (66.9M). OBIO has less debt than ETNB: OBIO (1.84M) vs ETNB (37.5M). OBIO has higher revenues than ETNB: OBIO (2.65M) vs ETNB (0).
ETNBOBIOETNB / OBIO
Capitalization1B116M866%
EBITDA-361.06M-59.81M604%
Gain YTD-12.276-22.25055%
P/E RatioN/AN/A-
Revenue02.65M-
Total Cash440M66.9M658%
Total Debt37.5M1.84M2,040%
TECHNICAL ANALYSIS
Technical Analysis
ETNBOBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
54%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 12 days ago
59%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMVX9.850.05
+0.48%
Invesco SteelPath MLP Select 40 R5
VICEX21.89N/A
N/A
USA Mutuals Vice Investor
LGRRX24.25N/A
N/A
Loomis Sayles Growth A
CFVLX32.41N/A
N/A
Commerce Value
GHTRX13.39N/A
N/A
Goldman Sachs International T/M Eq R6

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-4.59%
AKRO - ETNB
57%
Loosely correlated
-4.67%
RCKT - ETNB
51%
Loosely correlated
-11.75%
IDYA - ETNB
49%
Loosely correlated
-4.77%
NTLA - ETNB
48%
Loosely correlated
-5.62%
ARWR - ETNB
47%
Loosely correlated
-4.96%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-11.65%
ABOS - OBIO
36%
Loosely correlated
-8.52%
RCKT - OBIO
35%
Loosely correlated
-11.75%
INSM - OBIO
34%
Loosely correlated
-0.15%
ADVM - OBIO
34%
Loosely correlated
-7.51%
BEAM - OBIO
33%
Loosely correlated
-10.93%
More